United States· US:71335-0617_f128ff41-2ad3-4a5b-a34c-13d6f8940f35
Oxaprozin
A oxaprozin product containing oxaprozin, registered in United States by Bryant Ranch Prepack. The same ATC class is registered in 4 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Oxaprozin is registered in 4 of 19 countries.
Countries holding a registration under ATC M01AE12 (oxaprozin), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 3 of them publish a price we can compare per daily dose
Oxaprozin · ATC M01AE12
4 / 19 countries
- Belgiumprice
- Finlandprice
- Japan
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- OXAPROZIN
- Manufacturer
- Bryant Ranch Prepack
- Country
- United States (US)
- ATC code
- M01AE12
- ATC class
- Oxaprozin
- Defined daily dose
- 0.9 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 14
- ndc11713350617130 TABLET in 1 BOTTLE (71335-0617-1)
- ndc11713350617220 TABLET in 1 BOTTLE (71335-0617-2)
- ndc11713350617314 TABLET in 1 BOTTLE (71335-0617-3)
- ndc11713350617460 TABLET in 1 BOTTLE (71335-0617-4)
- ndc11713350617590 TABLET in 1 BOTTLE (71335-0617-5)
- ndc1171335061766 TABLET in 1 BOTTLE (71335-0617-6)
- ndc117133506177120 TABLET in 1 BOTTLE (71335-0617-7)
- ndc1171335-0617-1
- ndc1171335-0617-2
- ndc1171335-0617-3
- ndc1171335-0617-4
- ndc1171335-0617-5
- ndc1171335-0617-6
- ndc1171335-0617-7
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
245 interactions on record for oxaprozin.
Graded by severity as the source publishes them — 57 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Oxaprozin · interactions on record
245 records
- 57 severe
- 140 moderate
- 5 minor
- 43 info
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- DalteparinB01AB04severe
- EnoxaparinB01AB05severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Oxaprozin in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Greece · Nisaid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/01c5733f-10ff-4f78-8681-dd77cba930c5 GET /v1/drugs/01c5733f-10ff-4f78-8681-dd77cba930c5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "600",
"substance": "OXAPROZIN",
"productndc": "71335-0617",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA208633",
"marketing_category": "ANDA"
}See everything about oxaprozin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.